NET PROFIT FORECAST: Net profit is expected to rise to 1.67 billion pounds from 1.05 billion pounds, according to a consensus provided by the company. London-listed shares in GSK are up 4.1% since the ...

The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by ...

British stocks climbed on Monday, with heavyweight healthcare and consumer companies leading gains, putting the blue-chip ...

Dividends from UK companies totalled £14.0bn during the first quarter of 2025 according to Computershare’s latest Dividend Monitor.

The development of gepotidacin was funded by the pharmaceutical company GSK, which is responsible for manufacturing the new ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a ...

Medical equipment supplier and pharma services outlet Thermo Fisher Scientific also said on Wednesday it estimated a $400 ...

Mobico shares today skidded 21% after the National Express owner announced the sale of its North American school bus ...

Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY, ...

Leading with purpose, building with powerBy Juliet ETEFEIn a world that often demands women to dim their light to fit in, Ms.

Amid threats of higher tariffs imposed by the United States globally, the United Kingdom will “turbocharge” its investment ...

The three senior business and industry experts to support the company’s UK and US growth as it prepares for market entry.